I. Hsuan Wang

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern

J. Jan, I-Hsuan Wang, Yi-Ling Lin, 2022, Emerging microbes & infections.